A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Open Access

A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer

DOI Full Paper Access

203

Citations

21

References

2004

Year

Srinivasan Madhusudan, Martin D. Foster, S. Muthuramalingam, Jeremy Braybrooke, Susan Wilner, Kulwinder Kaur, Cheng Han, Susan Hoare, Frances R. Balkwill, Denis Talbot,

Clinical Cancer Research

Abstract

Our study shows the safety and biological activity of Etanercept in breast cancer and provides data to assess pharmacodynamic endpoints of different schedules of Etanercept and combinations with chemotherapy or other biological therapies.

References

	Year	Citations

Page 1